Description

Difosfocin (Citicoline) Solution for Injections 1000 mg/4 ml. 4 ml. Ampoules №3

Ingredients:

Each 4 ml ampoule contains 1000 mg of Citicoline.

Dosage:

The usual dosage is 1000 mg (1 ampoule) per day, administered via intramuscular or intravenous injection.

Indications:

Difosfocin is indicated for the treatment of acute ischemic stroke, traumatic brain injury, and cognitive disorders of vascular origin.

Contraindications:

Do not use Difosfocin in patients with hypersensitivity to Citicoline or any other component of the formulation.

Directions:

Administer Difosfocin as directed by a healthcare provider. It is recommended to follow aseptic techniques during administration.

Scientific Evidence:

Citicoline, the active ingredient in Difosfocin, has been extensively studied for its neuroprotective and cognitive-enhancing effects. Research suggests that Citicoline may improve cognitive function, enhance memory, and support brain health by increasing phospholipid synthesis in neuronal membranes.

Clinical trials have demonstrated the efficacy of Citicoline in improving neurological outcomes in patients with acute ischemic stroke and traumatic brain injury. Citicoline’s mechanism of action involves enhancing brain metabolism, reducing neuronal damage, and promoting neuroplasticity.

Additional Information:

It is important to monitor patients for any signs of allergic reactions or adverse effects during treatment with Difosfocin. Additionally, Difosfocin should be stored as per the manufacturer’s instructions to maintain its stability and efficacy.

Consult a healthcare professional for personalized recommendations and to discuss the potential benefits of Difosfocin in your specific condition.